Skip to main content

Safety constiderations in the use of intraoperative intraperitoneal chemotherapy

  • Chapter
Peritoneal Carcinomatosis: Principles of Management

Part of the book series: Cancer Treatment and Research ((CTAR,volume 82))

Abstract

The drugs frequently used intraoperatively within the abdomen and pelvis at the present time are cisplatin and mitomycin C. Both of these drugs are used at 43°C for 1–2 hours at maximal systemic doses of the drugs. The major toxicity of these drugs is renal impairment, which can be minimized by maintenance of a brisk diuresis, thus protecting all patients with normal renal function. In our experience with these renal toxic drugs, the safest place for their administration is the operating room. Monitoring the urine output at 15 minute intervals should eliminate drug pooling in the kidney tubules and consequent renal tubular insult. Large volumes of fluid can be safely used without fear of pulmonary edema because patients are endotracheally intubated and on positive pressure ventilation. Renal dopamine at 3μg/kg/min is regularly used in order to promote a diuresis. If urine output falls below 100 ml every 15 minutes, then a diuretic is given as an intravenous bolus. Generally furosemide administered at 10–20mg will result in more than a liter of urine in only a few minutes time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Maeta M, Hamazoe R, Koga S. Biological and clinical effects of whole-body hyperthermia for patients with disseminated malignancy. In Matsuda T, ed. Cancer Treatment by Hyperthermia, Radiation and Drugs. Bistol, PA: Tayor & Francis, 1993, pp 366–375.

    Google Scholar 

  2. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N, Takamizawa H. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36–41.

    Article  PubMed  CAS  Google Scholar 

  3. Fernandez-Trigo U, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C. In Sugarbaker PH, ed. Peritoneal Carcinomatosis: Drugs and Diseases. Norwell, MA: Kluwer Academic Publishers, 1996, pp 51–61.

    Chapter  Google Scholar 

  4. Stephens AD, Belliveau JF, Sugarbaker PH. Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and Sarcomatosis. In Sugarbaker PH, ed. Peritoneal Carcinomatosis: Diagnosis and Management. Norwell, MA: Kluwer Academic, 1995, pp 15–30.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

White, S.K., Stephens, A.D., Dowjat, B., Sugarbaker, P.H. (1996). Safety constiderations in the use of intraoperative intraperitoneal chemotherapy. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Principles of Management. Cancer Treatment and Research, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1247-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1247-5_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8531-1

  • Online ISBN: 978-1-4613-1247-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics